[1] Duhois B,FeIdman HH,Jacova C,et al. Advancing research diagnostic criteria for AIzheimer's disease:The IWG-2 criteria[J].Lancet Neurol,2014,13(6):614-629.
[2] Chen CS,Ouyang P,Yeh YC,et al.Apolipopmtein E polymorphism and behavioral and psychological symptoms of dementia in patients with Alzheimer disease[J].Alzheimer Dis Assoc Disord,2012,26(2):135-139.
[3] 胥丽霞,王景涛.载脂蛋白E基因多态性与阿尔茨海默病精神行为症状的关系[J].中国老年学杂志,2016,36(10):2484-2486.
[4] Rasmussen L, Delabio R, Horiguchi L, et al. Association between interleukin 6 gene haplotype and Alzheimer's disease:a Brazilian case-control study[J]. J Alzheimers Dis,2013,36(4):733-738.
[5] Lainscak M, von Haehling S, Doehner W, et al. The obesity paradox in chronic disease:facts and numbers[J]. J Cachexia Sarcopenia Muscle, 2012, 3(1):1-4.
[6] Besser LM, Gill DP, Monsell SE, et al. Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease[J]. Alzheimer Dis Assoc Disord, 2014, 28(1):36-43.
[7] Toledo JB, Tpledo E, Michael MW, et al. Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's disease neuroimaging initiative[J].Alzheimers Dement,2012, 8(6):483-489.
[8] Berti V, Murray J, Davies M, et al. Nutrient patterns and brain biomarkers of Alzhemer's disease in cognitively normal individuals[J]. J Nutr Health Aging,2015,19(4):413-423.
[9] Vidoni ED, Townley RA, Honea RA, et al. Alzheimer disease biomarkers are associated with body mass index[J]. Neurology, 2011,77(21):1913-1920.
[10] Hixson JE,Vernier DT. Restriction isotyping of human apolipo protein E by gene amplification and cleavage with Hha Ⅰ[J].J Lipid Res,1990,31(3):545-548.
[11] Caroli AI, Prestia A, Chen K, et al.Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F -FDG PET:head-to head comparison[J].J Nucl Med,2012,53(4):592-600.
[12] Shea YF, Joyce HA, Lee SC, et al. Impact of 18FDG PET and 11C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong[J].Hong Kong Med J, 2016,22(4):327-333.
[13] Kemppainen NM,Aalto S,Wilson IA,et al.Voxei-based analysis of PET amyloid ligand 11C-PIB uptake in Aizheimer disease[J].Neurology,2006,67(9):1575-1580.
[14] Mintun MA,LaRessa GN,Sheline YI,et al.11C-PIB in a nonde mented population potential antecedent nlarker of Alzheimer disease[J].Neurolagy,2006,67(3):446-452.
[15] David C, Hsu, Elizabeth C,et al.Lower late-life body-mass index is associated with higher cortical amyloid burden in clinically normal elderly[J]. J Alzheimers Dis, 2016, 53(3):1097-1105.
[16] Erta M, Quintana A, Hidalgo J. Inter leukin-6, a major cytokine in the central, nervous system[J]. Int J Biol Sci,2012,8(9):1254-1266.
[17] Chakrabarty P, Jansen West K, Beccard A, et al. Massive gliosis induced by inter leukin-6 suppressed abeta deposition in vivo:evidence against in flammation asadriving force for a myloid deposition[J]. FASEB J,2010,24(2):548-559.
[18] Cojocaru M, Miu G.Study of inter leukin-6 peoduction in Alzheimer's disease[J].Rom J Inter Med,2011,49(1):55-58.
[19] 唐丽娜,许小明,李艳红,等,炎症因子与阿尔茨海默病的相关性研究进展[J].中国老年学杂志,2016,36(17):4378-4380.
[20] Harold D, Abraham R, Hollingworth P,et al. Genome-wide association study identifies variants at CLU and PICALM as sociated with Alzheimer's disease[J]. Nat Genet,2009,41(10):1088-1093.
[18] HuangY,MuckeL.Alzheimer mechanisms and therapeutic strategies[J].Cell,2012,148(6):1204-1222.
[21] 郑磊,张凤春,李玉妹,等.APOEε4等位基因与尿AD7c-NTP联合检测在阿尔茨海默病早期诊断中的价值[J].中国老年学杂志,2016,36(12):2914-2916.
[22] 代学扬,蔡莉,王颖,等.动态增强CT与18F-FDGPET-CT对肝脏占位病变诊断价值的比较研究[J].中国实用内科杂志,2015,35(增1):103-104. |